BNC KOREA, Inc.

₩2,185As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:256840Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 2.02%
Div yield 3.20%
ROE (2.69%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.16
PE TTM —
TSR TTM (56.22%)
Mkt cap ₩149.4B
ROIC (3.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,347
7.41%
50.57%
Hold 7|11|5|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
25.06
25.33
25.17
25.12
23.70%
13.09%
16.14%
3.55%
Revenue₩B
6.802
6.875
7.190
7.527
5.33%
8.22%
11.67%
13.19%
Peers (US$110.2M)
Cap (US$)
PE
106.9M
26.43x
106.3M
3.616x
110.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.385
0.100
0.086
EBIT/Intx
7.569
0.270
0.254
Own earn%
(90.19)
169.53
160.24
Sh yield%
38.76
15.76
13.94
Owners
Insiders/Inst%
7.02
40.54
Short interest%
0.80
SBC / revenue%
5.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
10